Breast Implant Rippling — Why It Happens and How It Is Corrected

An implant shell is flexible rather than rigid. It can form shallow folds as its gel or saline shifts and as the surrounding pocket changes with posture. When there is enough stable tissue over those folds, they remain hidden. When coverage is thin, stretched, scarred, or poorly supported, the fold can become palpable rippling, visible implant rippling, or both.

Palpable rippling can be felt despite a smooth surface. Visible rippling reaches the skin, sometimes only while leaning or contracting the chest muscle. Neither grades implant integrity. A new focal change, pain, swelling, firmness, or distortion needs assessment for rupture, contracture, fluid, and malposition.

Location and behavior provide clues. Upper-pole or cleavage rippling commonly points to limited tissue cover over an implant edge. Lower or outer rippling can reflect an implant fold within a looser pocket. Traction rippling looks like lines pulled into the skin by a capsule or adherent tissue. A wave that appears only in one posture is mechanically different from a fixed indentation, although more than one pattern can coexist.

A central practical factor is the amount and quality of tissue between implant and skin. A naturally slim patient may have little subcutaneous fat. Pregnancy, weight loss, aging, glandular thinning, mastectomy, or previous operations can further reduce or scar the envelope. The same implant fold that is invisible under thicker tissue may be obvious under a thin upper pole.

Coverage is not uniform: the upper and inner breast often have less padding, while the lower pole may stretch. Consultation assesses local thickness, skin recoil, gland distribution, chest shape, scars, posture, and muscle contraction. A body-mass measure cannot replace that examination.

An implant that is too wide or heavy for its envelope places an edge under poorer coverage and can stretch tissue. Projection alone does not cause rippling, but excessive volume or width can expose folds. Downsizing helps only when dimensions contribute.

Saline moves freely, and an underfilled saline shell is prone to folding. Cohesive silicone holds form more consistently but can still ripple. Observational reconstruction data do not prove that progressively firmer gel always means less rippling in cosmetic augmentation.

Implant surface affects friction, capsule attachment, and mobility, but evidence rarely isolates smooth or textured surface from design, plane, and tissue thickness. Surface also carries other safety considerations, so it should not be chosen as a stand-alone rippling treatment.

Subglandular placement leaves gland and fat, but no pectoralis muscle, over the implant. In a thin patient, moving a suitable revision to a submuscular or dual plane can add coverage where upper and medial rippling is visible.

Dual plane placement keeps muscle over the upper implant while allowing controlled lower expansion. Its value is the distribution of cover: useful muscle is preserved, release is limited, and the pocket is stabilized. Trade-offs include animation deformity, discomfort, and displacement.

A plane change does not thicken the lower or far-lateral breast, and scar can limit movement. Rippling location therefore guides the plane rather than a blanket preference.

Rippling is more likely to be noticed when local tissue is thin, an implant is subglandular, implant width or weight exceeds the available coverage, a saline shell is underfilled, or weight loss and pregnancy have relaxed the envelope. Reconstruction and repeated revision can also leave less native tissue and more scar. These are contributors, not predictions: a patient can have several and little visible rippling, or develop rippling without one dominant factor.

Early folds can change as swelling settles. Later progression may reflect thinning tissue, pocket expansion, implant position, or capsule change; an observational association does not prove an individual cause.

Prevention starts with anatomy-based limits. The surgeon matches implant width and volume to the chest and tissue envelope, chooses a fill and profile that do not force an unsupported edge, and plans a pocket that provides coverage where it is needed. For a thin upper pole, muscle coverage through a suitable submuscular or dual plane may reduce visibility. Careful pocket control also reduces avoidable folding and edge migration.

These steps reduce modifiable risk but cannot hide an implant in every position. Tissue changes with age, weight, pregnancy, and gravity. Consultation should explain where an edge may remain palpable and whether a smaller implant preserves coverage. Early support cannot overcome inadequate tissue thickness.

Diagnosis is mainly clinical. The breast is inspected upright and while leaning, with the arms in different positions and, when relevant, during pectoralis contraction. Palpation maps whether the change is an implant edge, a mobile fold, a fixed tether, a capsule, or a separate breast lump. Comparing both sides and reviewing older photographs helps establish whether the finding is stable or progressive.

Ultrasound can assess shell integrity, fluid, capsule, rotation, or another mass; MRI can clarify uncertainty. A scan without rupture does not resolve the significance of a visible change, and failure to reproduce a positional wave does not erase it. Imaging and examination are complementary.

Much of the published evidence is observational and mixes reconstruction with cosmetic augmentation, different placement planes, implant designs, tissue substitutes, and follow-up periods. Reconstruction findings are useful for understanding mechanisms, but a breast after mastectomy does not have the same tissue envelope as a primary cosmetic augmentation. Associations should not be presented as proof that cohesivity, surface, or plane alone caused or prevented rippling.

Registries and manufacturer files may contain voluntary reports. Under-reporting, duplicates, missing details, reporting bias, and an uncertain denominator prevent true rate or causation estimates. Few reports or imaging non-detection do not prove safety or absence.

If rippling is only palpable, stable, and acceptable to the patient, observation is reasonable after other problems have been excluded. Revision becomes a preference-sensitive decision when visibility, discomfort, or contour is significant. The aim is to correct the dominant mechanism while avoiding a larger operation than the tissues require.

A plane change can move a subglandular implant beneath muscle or into a dual plane to improve upper coverage. Pocket repair can narrow an over-wide space or release a tether. Implant exchange can adjust width, volume, fill, or cohesivity; downsizing is particularly relevant when the existing implant exceeds tissue support. No implant label alone guarantees correction, and a firmer device may trade softness for shape stability.

Limited fat grafting can add upper or medial coverage, but some fat does not survive, staging may be needed, and later imaging can show fat-related changes. Matrix or mesh is selective: added material, infection risk, cost, and limited comparative evidence require discussion.

Recovery depends more on the operation than on the word rippling. A limited implant exchange differs from a plane change with capsule work, pocket reconstruction, or fat grafting. Early swelling can temporarily mask or exaggerate surface irregularity, so the first postoperative appearance is not the final contour. Activity limits, garment use, incision care, and review timing should follow the individual operative plan.

Residual or recurrent rippling is possible because tissue remains thin and can change. Increasing swelling, redness, fever, severe pain, or sudden distortion needs prompt contact.

A patient traveling to Gangnam should begin with photographs taken upright, leaning, and in the position that reveals the wave, plus the implant card, operative report, prior imaging, and a timeline of weight or breast changes. A remote review can identify likely contributors, but touch, posture-dependent examination, and ultrasound when indicated are needed before a definitive plan. Umnagumo is dedicated exclusively to breast surgery, but that clinical focus does not guarantee a correction or make every patient a candidate.

A useful consultation estimate is component-based: implant exchange and any size change, pocket or plane revision, capsule or tether release, limited fat grafting, selective reinforcement material, anesthesia, facility care, garments, medications, and follow-up. No concrete quotation is meaningful until the tissue and existing pocket are assessed. Patients should ask what is optional, what is included, how staged fat grafting would be priced if later needed, and who manages concerns after they return home.

Travel dates should allow in-person confirmation, surgery, early checks, and clearance to fly. The goal is a proportionate pocket and coverage plan, not one favorable photograph.